Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-1 alpha inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 3 D009369 ClinicalTrials
Colorectal Neoplasms 3 D015179 ClinicalTrials
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials
Hidradenitis Suppurativa 2 D017497 ClinicalTrials
Dermatitis, Atopic 2 D003876 ClinicalTrials
Acne Vulgaris 2 D000152 ClinicalTrials
Scleroderma, Systemic 2 D012595 ClinicalTrials
Pyoderma 2 D011711 ClinicalTrials
Psoriasis 2 D011565 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109653
FDA SRS N6SVN735GY